None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) males and females aged 20 to 39; (2) the presence of unexplained fatigue that is continuous and repetitive for more than 6 months; (3) not chronic fatigue syndrome and idiopathic chronic fatigue; (4) agreement of doctor diagnosis; and (5) those who consent to participate in this trial and sign an informed consent statement after listening to a clear explanation of the purpose and characteristics of this clinical trial
Exclusion criteria
Exclusion criteria: (1) over 14 score of Perceived Stress Scale-10item(PSS-10item); (2) disagreement of 2 doctors' diagnoses; (3) the presence of the following conditions in the subject’s past history that might trigger chronic fatigue: (a) organic causes, such as acute or chronic liver disease (for example, hepatitis, liver cirrhosis), anemia, tuberculosis, chronic lung disease, cardiovascular disease (for example, heart failure, hypertension), endocrine/metabolic disease (for example, diabetes, thyroid gland disease, severe obesity), autoimmune disease (for example, rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis), malignant tumors, or infectious disease; and (b) psycho-social causes, such as depression, anxiety neurosis, recent severe stress, schizophrenia, alcoholism, or an eating disorder (anorexia nervosa, bulimia nervosa); (4) subjects who have taken the following drugs within the past 2 weeks: antihypertensive drugs, antidepressants, anti-anxiety agents, hypnotics, or antihistamines; (5) pregnant or breast-feeding women; (6) subjects who are participating in other clinical trials; (7) subjects who are overworked; (8) subjects who have experienced a hypersensitive reaction after clinical laboratory test; (9) subjects who equipped to a cardiac pacemaker ; (10) subjects who do not provide informed consent; and (11) others whose clinical trial conductors are considered inappropriate for participating in this trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Questionnaire results on the syndrome differentiation of consumptive disease | — |
Secondary
| Measure | Time frame |
|---|---|
| Korean medical doctors' diagnosis results on the syndrome differentiation ;Health-related clinical pathology examination results;Score of stress response inventory (Fatigue Severity Scale, Chalder Fatigue Scale);Analytical variables of tongue image obtained through tongue imaging system;Output variables of dermometer (DDFAO) | — |
Countries
Korea, Republic of
Contacts
Cheonan Korean Medicine Hospital of Daejeon University